Pune, India, July 26, 2019 (GLOBE NEWSWIRE) -- According to a new report published by Market Research Future titled," Atorvastatin API Market by Application, Region, End-user: Global Size, Share, Growth, Opportunity Analysis and Industry Forecast to 2023."
Market Highlights
The global atorvastatin API market is estimated to be valued at USD 4,25,804.16 thousand by 2023 and is expected to register a CAGR of 3.34% during the forecast period.
The hypercholesterolemia segment is expected to lead the market and register a substantial CAGR to reach USD 2,10,753.23 thousand by the end of 2023. High prevalence of hypercholesterolemia is expected to drive the atorvastatin API market growth. Additionally, the segment is projected to exhibit the highest CAGR of 4.09% from 2018 to 2023.
North America accounted for the largest market share of 40.64% in 2017, and the regional market is projected to register a CAGR of 3.10% during the forecast period. Asia-Pacific is expected to register the fastest CAGR. The Chinese market is projected to exhibit the highest growth rate of 5.86% during the forecast period from 2018 to 2023.
Request Free Sample at https://www.marketresearchfuture.com/sample_request/7885
Market Key Players
Market Research Future (MRFR) recognizes Teva Pharmaceutical Industries Ltd (Israel), Jubilant Life Sciences Ltd (India), Dr. Reddy’s Laboratories Ltd (India), Sun Pharmaceutical Industries Ltd (India), Ind-Swift Labs Ltd (India), Morepen Laboratories Ltd (India), Zhejiang Hisun Pharmaceutical Co Ltd (China), Anuh Pharma Ltd (India), Centrient Pharmaceuticals (The Netherlands), and Cadila Pharmaceuticals (India) as the key players in the global atorvastatin API market.
Segment Analysis
The hypercholesterolemia segment is expected to lead the market and register a substantial CAGR to reach USD 2,10,753.23 thousand by the end of 2023. High prevalence of hypercholesterolemia is expected to drive the market growth. Additionally, the segment is projected to exhibit the highest CAGR of 4.09% from 2018 to 2023.
Regional Analysis
North America accounted for the largest market share of 40.64% in 2017, and the regional Atorvastatin API Market is projected to register a CAGR of 3.10% during the forecast period. Asia-Pacific is expected to register the fastest CAGR. The Chinese market is projected to exhibit the highest growth rate of 5.86% during the forecast period from 2018 to 2023.
The European Atorvastatin API market is estimated to exceed USD 1,31,094.04 thousand by 2023. High prevalence of hypercholesterolemia and mixed dyslipidemia are driving the growth of the Atorvastatin API market in the region. France is the major contributor to the growth of the regional market, followed by the UK.
Browse the market data and information spread across 85 pages with 65 data tables and 16 figures of the report “Atorvastatin API Market - Forecast to 2018-2023” in-depth alongside table of content (TOC) at: https://www.marketresearchfuture.com/reports/atorvastatin-api-market-7885
Key Findings of the Study:
- The global Atorvastatin API market is projected to reach over USD 4,25,804.16 thousand by 2023 at 3.34% CAGR during the review period of 2018 to 2023.
- North America accounted for the largest market share with the US being the major contributor to the growth of the market.
- The hypercholesterolemia segment is projected to register the highest CAGR of 4.09% during the forecast period owing to the rising rate of hypercholesterolemia cases.
- Key manufacturers are adopting geographic expansions, corporate acquisitions, and product launches as growth strategies.
Intended Audience
- Atorvastatin API Manufacturers
- Pharmaceutical Companies
- Contract Research Organizations
- Contract Manufacturing Organizations
Make an Enquiry Before Buying this Report @ https://www.marketresearchfuture.com/enquiry/7885
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services.
MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.
In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.